Can Fite Biofarma Ltd (CANF)
2.15
-0.01
(-0.46%)
USD |
NYAM |
Nov 04, 16:00
2.185
+0.04
(+1.63%)
After-Hours: 20:00
Can Fite Biofarma Enterprise Value: 8.379M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 8.379M |
| November 01, 2024 | 8.440M |
| October 31, 2024 | 8.379M |
| October 30, 2024 | 9.111M |
| October 29, 2024 | 9.416M |
| October 28, 2024 | 9.964M |
| October 25, 2024 | 10.70M |
| October 24, 2024 | 10.57M |
| October 23, 2024 | 11.43M |
| October 22, 2024 | 12.46M |
| October 21, 2024 | 13.13M |
| October 18, 2024 | 12.77M |
| October 17, 2024 | 11.73M |
| October 16, 2024 | 11.73M |
| October 15, 2024 | 12.04M |
| October 14, 2024 | 10.63M |
| October 11, 2024 | 10.27M |
| October 10, 2024 | 8.989M |
| October 09, 2024 | 9.598M |
| October 08, 2024 | 7.709M |
| October 07, 2024 | 7.465M |
| October 04, 2024 | 7.282M |
| October 03, 2024 | 7.130M |
| October 02, 2024 | 7.221M |
| October 01, 2024 | 7.16M |
| Date | Value |
|---|---|
| September 30, 2024 | 7.526M |
| September 27, 2024 | 7.587M |
| September 26, 2024 | 7.770M |
| September 25, 2024 | 7.648M |
| September 24, 2024 | 7.709M |
| September 23, 2024 | 7.709M |
| September 20, 2024 | 7.343M |
| September 19, 2024 | 7.587M |
| September 18, 2024 | 8.379M |
| September 17, 2024 | 8.318M |
| September 16, 2024 | 9.660M |
| September 13, 2024 | 9.903M |
| September 12, 2024 | 10.15M |
| September 11, 2024 | 9.294M |
| September 10, 2024 | 9.477M |
| September 09, 2024 | 8.989M |
| September 06, 2024 | 9.416M |
| September 05, 2024 | 9.464M |
| September 04, 2024 | 9.538M |
| September 03, 2024 | 8.806M |
| August 30, 2024 | 8.806M |
| August 29, 2024 | 8.989M |
| August 28, 2024 | 8.144M |
| August 27, 2024 | 8.088M |
| August 26, 2024 | 8.646M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.721M
Minimum
Apr 12 2023
41.86M
Maximum
Mar 16 2021
11.43M
Average
10.08M
Median
Aug 01 2022
Enterprise Value Benchmarks
| Compugen Ltd | 54.84M |
| Pluri Inc | 24.31M |
| BioLine Rx Ltd | 23.55M |
| XTL Biopharmaceuticals Ltd | 7.905M |
| BiomX Inc | 13.85M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.652M |
| Revenue (Quarterly) | 0.155M |
| Total Expenses (Quarterly) | 1.989M |
| EPS Diluted (Quarterly) | -1.517 |
| Profit Margin (Quarterly) | -1.07K% |